ARMP vs. LXRX
ARMP (Armata Pharmaceuticals Inc.) and LXRX (Lexicon Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ARMP returned -30.31%/yr vs -17.59%/yr for LXRX. Their 0.08 correlation means their historical movements had little consistent relationship.
Performance
ARMP vs. LXRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARMP achieves a -27.71% return, which is significantly lower than LXRX's 100.87% return. Over the past 10 years, ARMP has underperformed LXRX with an annualized return of -30.31%, while LXRX has yielded a comparatively higher -17.59% annualized return.
ARMP
- 1D
- -5.02%
- 1M
- -22.92%
- 6M
- -32.24%
- YTD
- -27.71%
- 1Y
- 78.74%
- 3Y*
- 21.04%
- 5Y*
- 3.46%
- 10Y*
- -30.31%
- ALL TIME*
- -32.73%
LXRX
- 1D
- -1.28%
- 1M
- -0.43%
- 6M
- 99.14%
- YTD
- 100.87%
- 1Y
- 115.89%
- 3Y*
- 5.99%
- 5Y*
- -8.18%
- 10Y*
- -17.59%
- ALL TIME*
- -14.75%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $728.24K | $797.82K | $910.24K | |
| $6.18M | $6.21M | $7.76M |
ARMP vs. LXRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARMP Armata Pharmaceuticals Inc. | -27.71% | 239.46% | -42.90% | 161.29% | -77.37% | 83.59% | -8.16% | 12.53% | -79.57% | -77.05% |
LXRX Lexicon Pharmaceuticals, Inc. | 100.87% | 55.72% | -51.73% | -19.90% | -51.52% | 15.20% | -17.59% | -37.50% | -32.79% | -28.56% |
Correlation
The correlation between ARMP and LXRX is 0.15, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.15 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.09 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2011 | 0.08 |
Fundamentals
ARMP:
$166.67M
LXRX:
$1.03B
ARMP:
-$7.78
LXRX:
-$0.07
ARMP:
37.38
LXRX:
12.46
ARMP:
$4.41M
LXRX:
$69.64M
ARMP:
$3.26M
LXRX:
$69.00M
ARMP:
-$27.14M
LXRX:
-$20.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARMP vs. LXRX — Risk / Return Rank
ARMP
LXRX
ARMP vs. LXRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Armata Pharmaceuticals Inc. (ARMP) and Lexicon Pharmaceuticals, Inc. (LXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARMP | LXRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.91 | ||
| Sortino ratioReturn per unit of downside risk | -0.06 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.27 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | 3.42 | -2.27 |
| Martin ratioReturn relative to average drawdown | 2.83 | 7.67 | -4.83 |
Loading charts...
Drawdowns
ARMP vs. LXRX - Drawdown Comparison
The maximum ARMP drawdown since its inception was -99.98%, roughly equal to the maximum LXRX drawdown of -99.91%. Use the drawdown chart below to compare losses from any high point for ARMP and LXRX.
Loading charts...
Drawdown Indicators
| ARMP | LXRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -99.91% | -0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -74.59% | -34.09% | -40.50% |
Max Drawdown (3Y)Largest decline over 3 years | -79.22% | -91.83% | +12.61% |
Max Drawdown (5Y)Largest decline over 5 years | -85.70% | -95.25% | +9.55% |
Max Drawdown (10Y)Largest decline over 10 years | -99.68% | -98.48% | -1.20% |
Current DrawdownCurrent decline from peak | -99.91% | -99.30% | -0.61% |
Average DrawdownAverage peak-to-trough decline | -82.94% | -93.30% | +10.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.19% | 15.17% | +15.02% |
Volatility
ARMP vs. LXRX - Volatility Comparison
Armata Pharmaceuticals Inc. (ARMP) has a higher volatility of 34.90% compared to Lexicon Pharmaceuticals, Inc. (LXRX) at 13.63%. This indicates that ARMP's price experiences larger fluctuations and is considered to be riskier than LXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARMP | LXRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 34.90% | 13.63% | +21.27% |
Volatility (6M)Calculated over the trailing 6-month period | 77.31% | 53.49% | +23.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 146.68% | 78.14% | +68.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 115.17% | 97.90% | +17.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 110.94% | 97.38% | +13.56% |
Dividends
ARMP vs. LXRX - Dividend Comparison
Neither ARMP nor LXRX has paid dividends to shareholders.
Financials
ARMP vs. LXRX - Financials Comparison
This section allows you to compare key financial metrics between Armata Pharmaceuticals Inc. and Lexicon Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARMP and LXRX have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARMP has higher volatility (34.90%) compared to LXRX (13.63%). In terms of maximum drawdown, ARMP dropped -99.98% vs LXRX's -99.91%.
LXRX currently has the higher Sharpe Ratio (1.49 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARMP and LXRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer